These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 19438459)
1. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459 [TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228 [TBL] [Abstract][Full Text] [Related]
3. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312 [TBL] [Abstract][Full Text] [Related]
4. Absence of BRAF and HRAS mutations in eruptive Spitz naevi. Gantner S; Wiesner T; Cerroni L; Lurkin I; Zwarthoff EC; Landthaler M; Hafner C Br J Dermatol; 2011 Apr; 164(4):873-7. PubMed ID: 21418173 [TBL] [Abstract][Full Text] [Related]
5. Spitz melanoma is a distinct subset of spitzoid melanoma. Raghavan SS; Peternel S; Mully TW; North JP; Pincus LB; LeBoit PE; McCalmont TH; Bastian BC; Yeh I Mod Pathol; 2020 Jun; 33(6):1122-1134. PubMed ID: 31900433 [TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384 [TBL] [Abstract][Full Text] [Related]
7. The spectrum of spitzoid tumours: A clinical study. Hafiji J; Rytina E; Burrows NP Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697 [TBL] [Abstract][Full Text] [Related]
8. BRAF and NRAS mutations in spitzoid melanocytic lesions. Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476 [TBL] [Abstract][Full Text] [Related]
9. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771 [TBL] [Abstract][Full Text] [Related]
10. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217 [TBL] [Abstract][Full Text] [Related]
11. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience. Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations. Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma. Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594 [TBL] [Abstract][Full Text] [Related]
14. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447 [TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours. van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740 [TBL] [Abstract][Full Text] [Related]
16. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. van Dijk MC; Bernsen MR; Ruiter DJ Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402 [TBL] [Abstract][Full Text] [Related]
17. High BRAF mutation frequency does not characterize all melanocytic tumor types. Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839 [TBL] [Abstract][Full Text] [Related]